Table 1

Demographic and clinical characteristics of study participants

CharacteristicGroup; mean ± SD*tp valueCohen d
BPD, n = 30Control, n = 28
Age, yr26.9 ± 6.126.5 ± 5.70.280.780.07
Intelligence (Raven)54.2 ± 4.254.1 ± 4.10.090.930.02
Body mass index23.0 ± 2.922.0 ± 2.51.400.170.37
Salivary testosterone, pg/mL26.9 ± 33.511.1 ± 12.32.340.0230.62
BPD symptom severity (ZAN-BPD)13.2 ± 5.00.5 ± 0.813.18< 0.0013.46
Depressiveness (BDI-II)27.5 ± 10.73.9 ± 3.411.12< 0.0012.92
ADHD symptom severity (ADHD-SR)14.45 ± 1.56.4 ± 1.14.32< 0.0011.14
Trait anxiety (STAI)59.5 ± 6.829.4 ± 5.918.03< 0.0014.74
Anger out (STAXI)15.1 ± 4.511.7 ± 3.83.100.0030.82
Comorbid disorder, no. current (lifetime)
 Affective disorders8 (22)
 Substance disorders0 (3)
 Anxiety disorders12 (15)
 PTSD7 (8)
 Social phobias5 (7)
 Somatoform disorders3 (3)
 Eating disorders7 (12)
 Antisocial personality disorder1 (1)
 Avoidant personality disorder10 (10)
  • ADHD = attention-deficit/hyperactivity disorder; ADHD-SR = Self-Rating Behaviour Questionnaire for ADHD; BDI-II = Beck Depression Inventory, revised; BPD = borderline personality disorder; PTSD = posttraumatic stress disorder; SD = standard deviation; STAI = State-Trait Anxiety Inventory; STAXI = State-Trait Anger Expression Inventory; ZAN-BPD = Zanarini Rating Scale for Borderline Personality Disorder.

  • * Unless indicated otherwise.